BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 24323636)

  • 1. Interferon-β and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays.
    Hart BJ; Dyall J; Postnikova E; Zhou H; Kindrachuk J; Johnson RF; Olinger GG; Frieman MB; Holbrook MR; Jahrling PB; Hensley L
    J Gen Virol; 2014 Mar; 95(Pt 3):571-577. PubMed ID: 24323636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus.
    Chan JF; Chan KH; Kao RY; To KK; Zheng BJ; Li CP; Li PT; Dai J; Mok FK; Chen H; Hayden FG; Yuen KY
    J Infect; 2013 Dec; 67(6):606-16. PubMed ID: 24096239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small-Molecule Antiviral β-d-
    Agostini ML; Pruijssers AJ; Chappell JD; Gribble J; Lu X; Andres EL; Bluemling GR; Lockwood MA; Sheahan TP; Sims AC; Natchus MG; Saindane M; Kolykhalov AA; Painter GR; Baric RS; Denison MR
    J Virol; 2019 Dec; 93(24):. PubMed ID: 31578288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques.
    Falzarano D; de Wit E; Rasmussen AL; Feldmann F; Okumura A; Scott DP; Brining D; Bushmaker T; Martellaro C; Baseler L; Benecke AG; Katze MG; Munster VJ; Feldmann H
    Nat Med; 2013 Oct; 19(10):1313-7. PubMed ID: 24013700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering a replication-competent, propagation-defective Middle East respiratory syndrome coronavirus as a vaccine candidate.
    Almazán F; DeDiego ML; Sola I; Zuñiga S; Nieto-Torres JL; Marquez-Jurado S; Andrés G; Enjuanes L
    mBio; 2013 Sep; 4(5):e00650-13. PubMed ID: 24023385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IFN-α2a or IFN-β1a in combination with ribavirin to treat Middle East respiratory syndrome coronavirus pneumonia: a retrospective study.
    Shalhoub S; Farahat F; Al-Jiffri A; Simhairi R; Shamma O; Siddiqi N; Mushtaq A
    J Antimicrob Chemother; 2015 Jul; 70(7):2129-32. PubMed ID: 25900158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papain-like protease.
    Yang X; Chen X; Bian G; Tu J; Xing Y; Wang Y; Chen Z
    J Gen Virol; 2014 Mar; 95(Pt 3):614-626. PubMed ID: 24362959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of interferon-lambda on restricting Middle East Respiratory Syndrome Coronavirus replication in the respiratory epithelium.
    Jeon YJ; Gil CH; Jo A; Won J; Kim S; Kim HJ
    Antiviral Res; 2020 Aug; 180():104860. PubMed ID: 32565134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A conformation-dependent neutralizing monoclonal antibody specifically targeting receptor-binding domain in Middle East respiratory syndrome coronavirus spike protein.
    Du L; Zhao G; Yang Y; Qiu H; Wang L; Kou Z; Tao X; Yu H; Sun S; Tseng CT; Jiang S; Li F; Zhou Y
    J Virol; 2014 Jun; 88(12):7045-53. PubMed ID: 24719424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe acute respiratory syndrome vs. the Middle East respiratory syndrome.
    Hui DS; Memish ZA; Zumla A
    Curr Opin Pulm Med; 2014 May; 20(3):233-41. PubMed ID: 24626235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines.
    Morgenstern B; Michaelis M; Baer PC; Doerr HW; Cinatl J
    Biochem Biophys Res Commun; 2005 Jan; 326(4):905-8. PubMed ID: 15607755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective Interferon Lambda Treatment Regimen To Control Lethal MERS-CoV Infection in Mice.
    Dijkman R; Verma AK; Selvaraj M; Ghimire R; Gad HH; Hartmann R; More S; Perlman S; Thiel V; Channappanavar R
    J Virol; 2022 Jun; 96(11):e0036422. PubMed ID: 35588276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Endonucleolytic RNA Cleavage Function of nsp1 of Middle East Respiratory Syndrome Coronavirus Promotes the Production of Infectious Virus Particles in Specific Human Cell Lines.
    Nakagawa K; Narayanan K; Wada M; Popov VL; Cajimat M; Baric RS; Makino S
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30111568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Suppresses Type I and Type III Interferon Induction by Targeting RIG-I Signaling.
    Chang CY; Liu HM; Chang MF; Chang SC
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32295922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Stress Granule Formation by Middle East Respiratory Syndrome Coronavirus 4a Accessory Protein Facilitates Viral Translation, Leading to Efficient Virus Replication.
    Nakagawa K; Narayanan K; Wada M; Makino S
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30068649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of immunomodulators, interferons and known in vitro SARS-coV inhibitors for inhibition of SARS-coV replication in BALB/c mice.
    Barnard DL; Day CW; Bailey K; Heiner M; Montgomery R; Lauridsen L; Chan PK; Sidwell RW
    Antivir Chem Chemother; 2006; 17(5):275-84. PubMed ID: 17176632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Middle East respiratory syndrome coronavirus infection by anti-CD26 monoclonal antibody.
    Ohnuma K; Haagmans BL; Hatano R; Raj VS; Mou H; Iwata S; Dang NH; Bosch BJ; Morimoto C
    J Virol; 2013 Dec; 87(24):13892-9. PubMed ID: 24067970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-α treatment.
    de Wilde AH; Raj VS; Oudshoorn D; Bestebroer TM; van Nieuwkoop S; Limpens RWAL; Posthuma CC; van der Meer Y; Bárcena M; Haagmans BL; Snijder EJ; van den Hoogen BG
    J Gen Virol; 2013 Aug; 94(Pt 8):1749-1760. PubMed ID: 23620378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin.
    Barnard DL; Day CW; Bailey K; Heiner M; Montgomery R; Lauridsen L; Winslow S; Hoopes J; Li JK; Lee J; Carson DA; Cottam HB; Sidwell RW
    Antiviral Res; 2006 Aug; 71(1):53-63. PubMed ID: 16621037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.